Because of the well-described imrnunosuppressive activities of IF, and the fact that mitogens are known to stimulate the production of IF by lymphocytes, we have examined the role of IF in the in vitro suppressive activity of concanavalin A (Con A)-activated human peripheral blood mononuclear cells. The results presented here will indicate that the suppressor activity of Con A-activated cells is mediated largely by IF and that similar suppressor activity can be generated by exposure of human peripheral blood leukocytes (PBL) to certain tumor cell lines, viruses, and specific antigen, which induce the production of IF.
Materials and Methods
Lymphocyte Preparation and Culture. PBL were prepared from venous blood by heparinization followed by Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piseataway, N. J.) sedimentation. For those experiments with the virus plaque assay (VPA) defibrination was used (18) . Culture medium for all experiments was RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 10% pooled human AB serum, glutamine, and antibiotics. PBL were cultured at 1 × 106 cells/ml of medium in 5-ml plastic tubes for the VPA (2 ml of cell suspension/tube) or in flat-bottomed microtiter plates (0.2 ml/well) for measurement of tritiated thymidine ([3H]TdR) incorporation. All cultures were done in triplicate. Con A (Miles Laboratories Inc., Miles Research Products, Elkhart, Ill.) was added to cultures at a final concentration of 30 /~g/ml. Cultures were incubated at 37°C in a humidified CO2 incubator for 72 h before addition of|3H]TdR or infection with virus.
VPA and Assay for Incorporation of [~ -H]TdR.
The VPA for enumerating activated human lymphocytes was carried out as described previously (18) . Briefly, lymphocytes were infected with vesicular stomatitis virus (VSV) at the end of the culture period, treated with guinea pig anti-VSV serum to neutralize free virus, washed, and plated over an indicator monolayer of L929 cells in an infectious centers assay. Virus plaque-forming cells (V-PFC) were then enumerated and expressed as V-PFC per 106 cells plated. Aliquots (0.2 ml) of the same cultures tested for V-PFC were removed before infection with virus and placed in microtiter wells. For assay of lymphocyte transformation, 1/~Ci of [3H]TdR (New England Nuclear, Boston, Mass.) was added to each sample in microtiter wells. Samples were harvested 6 h later in a multiple cell culture harvester (Skatron, Flow Laboratories, Inc., Rockville, Md.) and counted in a Beckman liquid scintillation counter (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.).
Generation of Modulator Cells and Supernates with Con A and PPD. Modulator cells were prepared
by culture of 2 × 106 PBL in 2 ml in plastic tubes with or without Con A (30/xg/ml) or PPD (20 #g/ml) for 72 h. PPD was obtained from the Ministry of Food, Fishery, and Agriculture, Weybridge, Surrey, England. In the case of Con A, modulator cells were washed with 0.1 M a-methylmannoside to remove residual Con A. Modulator cells (1 × 106) were then treated with mitomycin C (50 ~g/ml for 30 rnin at 37°C) and added to equal numbers of freshly prepared autologous or allogeneic responder cells, cultured for an additional 72 h in the presence or absence of Con A, and then assayed for V-PFC or incorporation of [3H]TdR. In the case of PPD-activated modulator cells, PPD-negative responder PBL were used. In experiments with modulator supernates, supernates from Con A-or PPD-activated PBLand from PBL cultured in medium alone were added to responder lymphoeytes at a final dilution of 1:1 in culture medium in the presence and absence of Con A and assayed for [3H]TdR incorporation after a 72-h incubation.
Tumor Cell-Lymphocyte Cocultures. Tumor cell-lymphocyte cultures were carried out as reported by Trinchieri and Santoli (11) with 5 × 10 ~ tumor cells and 5 × l0 s PBL in 16-mm wells. As controls, lymphocytes were cultured in the absence of tumor cells, and tumor cells in the absence of lymphocytes. Lymphocytes and supernates were harvested after 24 h. Lymphocytes to be used as modulator cells were treated with mitomycin C and added to equal numbers of freshly prepared autologous or allogeneic responder cells. Supernates from these.cultures were centrifuged at 400 g, millipored to remove cell debris, and added to responder cells at a Newcastle Disease Virus (NDV) Treatment of PBL. NDV was grown in chick embryo fibroblasts, harvested at the time of maximal cytopathic effect, yielding 5 × 10 7 PFU/ml, and inactivated with fl~6propiolactone (0.15%, 37°C, 2 h) (25) . Ficoll-Hypaque-prepared PBL were euhured at 2 × 10 cells/ml with inactivated NDV (10~/ml) at 37°C for 48 h. IF-containing supernates were centrifuged at 30,000 g at 4°C for 3 h to remove virus. The supernate used in all experiments contained 3,170 U of antiviral activity/ml. K. Paucker (Medical College of Pennsylvania, Philadelphia, Pa.) (and kindly provided by Dr. G. Galasso, Infectious Disease Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Md.). This serum was raised against Sendai virus-induced leukocyte IF and has an antibody titer of 10,000 U/ml against human leukocyte IF and 240 U/ml against human fibroblast IF. The antiserum was added to modulator-responder cultures at a final dilution of 1:100 at the start of the culture period. A sheep anti-human leukocyte interferon serum was kindly provided by Dr. K. Cantell (Central Public Health Laboratory, Helsinki, Finland) and was similarly used in some experiments.
Treatment at pH 2. Supernates were dialyzed 24 h at 4°C in RPMI (pH 7.4) or in RPMI acidified to pH 2 by addition of 4 N HCI and then dialyzed an additional 24 h in RPMI. All supernates were checked for pH at the end of the dialysis period and millipored. Supernates were assayed for antiviral activity and suppression before and after dialysis at pH 7.4 and pH 2.
Results
Suppression by Con A-activated Modulator Cells. In our initial studies, we compared the effects of Con A-induced modulator cells in two assays for lymphocyte activation, the lymphocyte transformation test and the VPA. The latter enumerates activated T cells by their ability to permit replication of VSV (18) . Lymphocytes treated for 3 d with or without Con A were treated with mitomycin C and used as modulator cells, which could influence the response of normal responder lymphocytes to Con A. The degree of suppression obtained with Con A-activated modulator cells on the Con A response of freshly prepared PBL was invariably greater in the VPA than in the [SH]TdR incorporation assay done on the same cultures (Fig. 1) . The mean percent suppression in a group of 15 normals observed in the VPA was 82.7% compared with 47.2% in the [SH]TdR assay. As reported by others (5), Con A-treated modulator cells were equally effective in suppressing the mitogen response of autologous or allogeneic responders.
Effect of Anti-Human Leukocyte IF Serum on Con A-stimulated PBL.
To explain the increased sensitivity of the VPA to the action of Con A-activated modulator cells, we considered the possibility that mitogen-induced IF might contribute to the observed suppression, perhaps affecting the generation of cells permissive to viral replication to a greater extent than the incorporation of [SH]TdR. To ascertain whether IF was involved in the suppression, we first investigated the effect of adding rabbit antihuman leukocyte IF serum to mitogen-stimulated cultures, and found that the number of Con A-stimulated V-PFC was increased, often as much as 200%, whereas the [SH]TdR incorporation in the same cultures increased by only 10-30% in most experiments. Unstimulated cultures (no Con A added) were unaffected by addition of the antiserum. A representative experiment is shown in Fig. 2 . There was some variation from donor to donor in sensitivity to the anti-IF serum, perhaps reflecting genetic differences in levels of IF production between different individuals, analogous to strain differences among mice (26) or production of different proportions of types I and II IF (see below). Supernates of Con A-activated PBL from normal individuals generally contained 100 U of IF/ml. Antiviral activity was virtually all (90-100%) eliminated after dialysis at pH 2, compatible with type II or immune IF. Addition of rabbit anti-human leukocyte IF to supernates of Con A-activated PBL before IF assay reduced antiviral titers by 70% in most experiments. This antiserum, which was raised against Sendai virus-induced leukocyte (type I) IF, thus was able to neutralize a portion of the antiviral activity of pH 2 labile mitogen-induced IF, which suggested either antigenic cross-reactivity between viral-and mitogen-induced IF or, alternatively, that the antiserum has multiple specificities. Similar reduction of the antiviral activity of supernates of Con A-activated PBL was observed with a sheep anti-human leukocyte IF serum in two experiments.
Addition of Anti-Human Leukocyte 1F Serum to Con A-treated Modulator-Responder Cultures. The role of IF in the Con A suppressor system was established when it was found in five separate experiments that the presence of anti-IF serum largely abrogated the Con A-induced suppression of the mitogen response. A representative experiment is shown in Table I . IF titers were often, but not always, significantly higher in the supernates of suppressed cultures. Culture supernates that contained anti-IF serum showed partial loss of antiviral activity in parallel with loss of suppression. Similar results were obtained with both sheep and rabbit anti-IF sera. Suppression of mitogen responses by supernates of Con A-activated ceils was also abrogated by addition of anti-IF to supernate-treated responder cells.
Suppression by PPD-activated Modulator Cells. When PBL from PPD-positive donors were cultured in the presence of PPD for 48 h, significant suppressor activity was obtained when these modulator cells were added to PPD-negative responder PBL stimulated with Con A. Supernates of such PPD-treated modulator cells contained 100-1,000 U of antiviral activity and suppressed the Con A responses of responder PBL. Conversely, modulator cells or supernates prepared from PPD-negative PBL treated with PPD failed to suppress or to exhibit antiviral activity. A representative experiment is shown in priming for the induction of IF by virus, thus appearing to be type I IF. At these low levels (0.5-1.5 U/ml in final culture medium), significant suppression by modulator cells or supernates was not seen. As will be shown in a later section (Fig. 5) supernates of PPD-activated PPD-sensitive PBL had antiviral activity that appeared to be a mixture of type I and type II IF. Table III . Lymphocytes removed from the MeWo cells after overnight incubation were themselves suppressed and strongly suppressed the Con A responses of freshly prepared responder cells, whereas lymphocytes cultured in the absence of melanoma cells failed to suppress. Supernates from the mixed cultures contained significant amounts of IF, whereas supernates from lymphocytes or melanoma cells cultured alone had no measurable antiviral activity. In some experiments, supernates from MeWo cells cultured alone suppressed and induced IF. IF induction and suppression by these supernates could be abolished by milliporing or by repeated freeze-thawing, a procedure that did not affect the antiviral or suppressor activities of IF-containing supernates. When added to responder cells after milliporing or freezethawing, only the MeWo-lymphocyte supernates suppressed. In experiments with modulator lymphocytes cultured on tumor lines, we were concerned that tumor cells might be carried over into modulator-responder cultures. Mitomycin treatment of PBL did not significantly affect their ability to make IF on coculture with MeWo cells; however, mitomycin-treated MeWo cells were unable to induce IF or suppressor Fig. 3 .
Generation of Suppressor
Addition of anti-human leukocyte IF serum to lymphocyte-tumor cell coculture modulator-responder cultures largely eliminated suppression by modulator cells and significantly reduced suppression by supernates. Treatment at pH 2 did not affect suppression by lymphocyte-tumor cell supernates, Similarly, the antiviral activity of these preparations was unchanged by pH 2, but was fully neutralized by anti-human leukocyte IF serum. (Results summarized in Fig. 5.) 
Suppression of the Con A Response by ND V-induced IF.
A supernate from PBL treated with fl-propiolactone-inactivated NDV contained 3,170 U of IF/mi. In the presence of varying dilutions of this material, the Con A response of normal PBL was suppressed. A representative experiment is shown in Fig. 4 . Significant suppression of the Con A response was seen at final concentrations of < 1 antiviral U/ml of culture suspension, thus demonstrating that viral-induced leukocyte IF is a potent immunoregulatory substance even at concentrations undetectable by a sensitive antiviral assay. Sensitivity of responder PBL to added IF was variable; some donors failed to be suppressed at levels of < 3 U/ml. Addition of anti-human leukocyte IF serum to these cultures completely eliminated suppression of the Con A response. Similarly the antiviral activity of this preparation was completely abolished by this antiserum. Antiviral activity was unaffected by treatment at pH 2.
Antiviral and Suppressive Activities of Supernates Produced by Various IF Inducers.
To determine whether suppression and antiviral activity are mediated by the same type(s) of IF, supernates from PBL cultured with Con A, NDV, PPD, and MeWo cells were dialyzed at pH 2, treated with anti-IF serum, or both, and were assayed for antiviral and suppressive activity. A representative experiment is shown in Fig. 5 . From the results shown it can be seen that the IF induced by NDV and MeWo cell coculture are neutralized by anti-IF serum but unaffected by pH 2. Similarly, suppression by these supernates is eliminated or markedly reduced by anti-IF but unaffected by pH 2 treatment. As shown in Fig. 5 , addition of anti-IF to tumor cocuhure supernates was unable to completely abrogate suppression as was the case with NDV-induced Supernates of PBL treated with NDV, Con A, PPD, and MeWo cells were diluted with medium to contain 100 U IF/ ml. and dialysed at pH 2 or treated with anti-IF serum or both. Supernates of PBL cultured in medium alone were similarly treated. Modulator and control supernates were then added to responder PBL (PPD negative) in the presence of Con A.
[aH]TdR incorporation was measured after 72 h, and percent suppression was calculated. Treated and untreated modulator supernates were assayed for antiviral activity on D532 ceils. Dialysis at pH 7.4 had no effect on suppressive or antiviral activity.
IF, which suggested that factors other than IF may also contribute to tumor cellinduced suppression. The Con A-and PPD-induced antiviral and suppressive activities appeared to be a mixture of classical type I and type II IF in that both pH 2 and anti-IF reduced both activities, whereas a combination of the two treatments eliminated them completely. It can be seen that suppressive and antiviral activities were affected in parallel in all cases, thus offering strong support that IF is a mediator of suppression in this system. Discussion In the past several years two major mechanisms of immunological suppression have been described, one specific the other not. The first to be described (27, 28) was a nonspecific suppression of antibody formation in vitro induced by mitogen stimulation of lymphocytes from experimental animals. Both mitogen-treated lymphocytes and soluble factors produced by them were found capable of restricting cellular immune responses as well (29) . The soluble factor responsible, termed "SIRS" (30) , had properties similar to migration inhibitory factor and has more recently been shown to be capable of correcting the defect in NZB mice in vivo responsible for their developing autoimmune disease (31) . The second mechanism of regulation demonstrated in experimental animals was the antigen-specific and genetically restricted control of antibody formation and cell-mediated immune reactions controlled by T cells (1) . Recently, evidence has been provided that indicates that this type of suppression can be mediated by a molecule that possesses specificity for antigen and determinants of I-region gene products (32) .
Because of the difficulty in carrying out studies on genetic restrictions in man, there are only a limited number of experiments that confirm the existence of human genetically restricted or antigen-specific T cell-mediated suppression (3, 4) . The principal tool used to study defects in the cell-mediated immunosuppressive mecha-nism has been the study of mitogen-induced suppressor cell activity. Considerable evidence exists that indicates that mitogen-activated human lymphocytes can suppress both in vitro cell-mediated and antibody responses, and that defects in this mechanism have been identified in such clinical entities as multiple sclerosis (33), lupus erythematosis (34) (35) (36) , and autoimmune syndromes (37) .
Although there is compelling evidence that T cells are involved in mitogen-induced suppression, it has not been possible to demonstrate rigorously that T cells are the only cells capable of mediating this response. In any case, the mechanism of the mitogen-induced suppressor activity of human lymphocytes and the nature of the soluble suppressor factor has not been elucidated.
The possible role of IF in Con A-induced suppressor activity of human lymphocytes was suggested by the finding that when two assays of lymphocyte activation were used as the detection system for monitoring Con A-induced suppression, the VPA invariably showed higher levels of suppression than did the incorporatio n of [3H]TdR. Because the virus used to detect lymphocyte activation in the VPA was VSV, known to be a sensitive indicator virus for IF assay, it seemed likely that the increase in sensitivity to Con A suppressor activity shown in the VPA was related to the sensitivity of the virus system for detecting IF activity. Although IF are defined by their antiviral activity, it is clear that they are capable of exerting a variety of functional and molecular changes in a variety of cell types (38) , At least three molecular species that possess IF activity have been defined. A number of laboratories have reported that one or more types of IF were capable of inducing suppression of T cell or B cell responses in vivo and in vitro (12) (13) (14) 39) .
The data presented here confirm an immunoregulatory function of IF and suggest that they may be the principal agents mediating mitogen-induced suppression of lymphocyte activation measured in vitro. The evidence in support of this conclusion is derived from the following observations: (a) There was a correlation between the suppressive activities of Con A-treated modulator lymphocytes and their ability to produce IF in vitro. By the indirect means available, it is difficult to define rigorously the species of IF that effects the nonantivirat activities being studied. In our experiments, NDVinduced IF from human leukocytes was found to be entirely pH 2 stable and completely neutralized by a rabbit and sheep anti-human type I leukocyte IF, and behaved as classically defined type I leukocyte IF. The PPD-induced immunosuppressive and antiviral activities were found to be partially pH 2 labile and partially affected by the antibodies to type I leukocyte IF, but completely neutralized by both treatments, thus having characteristics of a mixture of both types of IF. The immunosuppressive and antiviral activities produced by the interaction of normal human leukocytes and human tumor cells had the properties of type I leukocyte IF. The Con A-induced suppressor and antiviral activity shared properties with both type I and type II IF. It was largely inactivated by treatment at, pH 2, and yet 70% of the activity was abolished by treatment with anti-type I leukocyte IF antiserum. Although alternative explanations are possible, e.g., that anti-type I IF sera have some crossreactivity with type II IF, or that there exists a subset of type I IF molecules that are pH 2 labile, the simplest interpretation would be that Con A-and PPD-stimulated human PBL produce both type I and type II leukocyte IF that mediate the observed suppressor activity. On the basis of the antibody neutralization studies, we would assume that ~ 70% of the suppressor activity of Con A-activated cells is mediated by type I leukocyte IF, and that 30%, not neutralizable with these sera, would represent type II IF. Because it has been clearly demonstrated that T cells can produce type II IF (40) and that a non-B non-T subset with characteristics of NK cells can produce type I IF (41), we would conclude that both lymphocyte subsets may be stimulated by Con A to carry out suppressor function in vitro.
We believe that the results described here might have useful application to the study of a number of human diseases, including lupus erythematosis and multiple sclerosis, in which a defect of mitogen-induced suppression has been described. Whether the primary defect is truly an immunoregulatory one, or is related to the failure to produce or to respond to IF might provide useful insights into the etiology and pathogenesis of these conditions. In this regard, it is of interest that there was a defect in virus-induced suppression in 32 of 36 patients with multiple sclerosis that was paralleled precisely by their inability to produce IF (42) . Recently it has been reported that immune IF is elevated in the serum of some patients with autoimmune disease (43) .
Secondly, Trinchieri and Santoli (11) reported that some human tumor cell lines are capable of stimulating the production of IF from normal human lymphocytes, whereas others are not. In the present experiments, we have confirmed this observation and extended it to demonstrate a parallel between their ability to induce IF and their ability to engender suppressor cells. Because of the importance of IF as an immunoregulatory molecule capable of stimulating NK cell activity and its demonstrated suppressor activity on lymphocyte, presumably T cell, activation, it will be of interest to study the antiviral and suppressive response of lymphocytes from patients with various forms of cancer to search for immunoregulatory defects in that disease.
Summary
Evidence is presented that interferon (IF) is a major mediator of the human concanavalin A (Con A) suppressor cell. The suppressive effects of Con A-activated lymphocytes on the mitogen responses of normal responder cells were largely abrogated by addition of anti-human leukocyte IF serum. Similar suppressor activity was generated by coculture of peripheral blood leukocytes (PBL) with a melanoma cell line (MeWo) and a HeLa cell line persistently infected with measles virus that induced the production of IF by lymphocytes. A human mammary carcinoma line (MCF-7) and two bladder carcinoma lines (T24 and TCCSUP) failed to induce IF or suppression. Addition of anti-human leukocyte IF serum to suppressor cells and supernates from tumor cell-lymphocyte cocuhures largely abolished suppression and neutralized the antiviral activity of such supernates. Exposure of PBL from purified protein derivative (PPD)-positive donors to PPD caused the production of suppressor activity and IF. PBL from PPD-negative donors failed to produce significant amounts of IF or to suppress on exposure to PPD. Supernates from PBL treated with virus (Newcastle disease virus [NDV]) contained IF and suppressed the mitogen responses of responder PBL. Both the suppressive and the antiviral activities of this material were eliminated after treatment with anti-IF serum. To ascertain whether antiviral and suppressive activities were mediated by the same types of IF, supernates from PBL cultured with Con A, PPD, NDV, and tumor cells were treated with anti-IF serum or acid pH. In all cases antiviral activity was neutralized in parallel with abrogation of suppressor activity. These results provide strong evidence for the role of IF as a mediator of human suppressor cell activity.
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